PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Daily consumption of EVOO improved vascular endothelial function and hemodynamic parameters in patients with hyperlipidemia [PMID:41373940]
EVOO is associated with a reduced incidence of cardiovascular events, including myocardial infarction and stroke [PMID:29141571]
EVOO polyphenols exhibit neuroprotective properties and may lower the risk of age-related pathologies due to high phenol concentration [PMID:32468462, PMID:41479097]
EVOO demonstrates anti-diabetic, hypolipidemic, anti-hypertensive, and anti-obesity actions [PMID:39125686]
EVOO components may play a protective role in mitigating cancer and inflammatory diseases [PMID:40732959]
Evidence summary
PubMed sources
- 1.PMID: 33576418 (2021) — Extra-virgin olive oil and the gut-brain axis: influence on gut microbiota, mucosal immunity, and cardiometabolic and cognitive health. · Nutrition reviews
- 2.PMID: 32468462 (2020) — Olive Oil Polyphenols in Neurodegenerative Pathologies. · Advances in experimental medicine and biology
- 3.PMID: 33172043 (2020) — Olive Oil: Processing Characterization, and Health Benefits. · Foods (Basel, Switzerland)
- 4.PMID: 40732959 (2025) — Extra Virgin Olive Oil (EVOO) Components: Interaction with Pro-Inflammatory Cytokines Focusing on Cancer and Skeletal Muscle Biology. · Nutrients
- 5.PMID: 39125686 (2024) — Extra Virgin Olive Oil and Metabolic Diseases.